Business
Organic Fried Tater Tots
(Getty Images)

Did Big Potato collude to keep tater tots expensive? One grocery store thinks so

Prices for frozen potato products have shot up, but one chart casts doubt on price-gouging accusations.

Four of the companies that control most of the country’s frozen-potato supply have been accused of brokering backdoor deals to keep their products expensive.

In a lawsuit filed last week, a Pennsylvania-based small grocery chain, Redner’s Markets, said a small group of companies that sell products like hash browns and tater tots colluded to artificially inflate prices starting in 2021. These companies — Cavendish Farms, Lamb Weston, McCain Foods, and the JR Simplot Company — control nearly all of the $68 billion frozen-potato market.

It’s true that the price of frozen potato products has skyrocketed and stayed high relative to other products, according to the Bureau of Labor Statistics Producer Price Index.

This is how the scheme went down, Redners alleges: the potato processors saw their costs shoot up in 2021, so they rose prices, but in 2022 when their costs started coming down, they all agreed to keep their prices high and pocket the wider margin.

Lamb Weston is the only company from the group that is publicly traded. As such, it’s the only one that allows us a peek under the hood. 

Looking at their financials, it’s clear that there was a shift after the pandemic, which is true for most companies. Its profit margins declined in 2020, 2021, and 2022. But after that, they jumped back up to over 25%, just over where they were before the pandemic. 

The company has said that its faced rising costs of production — the raw potatoes and labor are more expensive than they used to be. Their costs did go up, and so did their sales.

Lamb Westons financial results alone are by no means a clear indication whether price fixing or price gouging is taking place or not. But on its face, at least for this specific company, there doesnt seem to be a smoking gun.

In a statement to Sherwood, a Lamb Weston spokesperson said they believe the claims are without merit and intend to vigorously defend our position. Cavendish Farms, McCain Foods, and the JR Simplot Company did not immediately respond to requests for comment.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.